In the current study, we analyzed clinical and MRI indexes of inflammatory activity in RRMS patients, whom we stratified by CSF detection of IL-1β during the clinical and radiological remission phase. The gene discussed is IL1B; the disease is relapsing-remitting multiple sclerosis.